4//SEC Filing
Patel Priti 4
Accession 0001209191-23-006881
CIK 0001404644other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:32 PM ET
Size
10.5 KB
Accession
0001209191-23-006881
Insider Transaction Report
Form 4
Patel Priti
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-02-01+35,000→ 45,462 total - Sale
Common Stock
2023-02-02$0.60/sh−14,380$8,588→ 31,082 total - Exercise/Conversion
Restricted Stock Units
2023-02-01−35,000→ 35,000 totalExercise: $0.00→ Common Stock (35,000 underlying)
Footnotes (6)
- [F1]Includes 2,000 shares of Common Stock acquired by the Reporting Person on May 13, 2022 and 2,000 shares of Common Stock acquired by the Reporting Person on November 15, 2022 pursuant to the Issuer's employee stock purchase plan.
- [F2]The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
- [F3]Represents the weighted average sale price. The lowest price at which shares were sold was $0.576 and the highest price at which shares were sold was $0.635. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth herein.
- [F4]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement for no consideration.
- [F5]The RSUs will vest as to 1/2 of the total number of shares underlying the award on each of February 1, 2023 and February 1, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F6]The RSUs do not expire; these securities either vest and settle or are canceled prior to the vesting date.
Documents
Issuer
Neoleukin Therapeutics, Inc.
CIK 0001404644
Entity typeother
Related Parties
1- filerCIK 0001859997
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:32 PM ET
- Size
- 10.5 KB